Ivermectin (12 mg) is an antiparasitic medicine indicated for the treatment of certain parasitic infections such as strongyloidiasis, onchocerciasis (river blindness), scabies and other susceptible helminthiases. Use only as prescribed by a healthcare professional.

Key benefits

• Broad-spectrum antiparasitic activity
• Convenient oral tablet dosage
• Manufactured to quality standards

Composition

Each tablet contains: Ivermectin 12 mg (active ingredient).

Usage directions

• Take exactly as prescribed by your doctor; do not self-medicate.
• Dosing varies by indication and body weight — follow prescriber instructions.
• May be taken with food to improve absorption unless advised otherwise.

Possible side effects

• Common: nausea, diarrhoea, dizziness
• Rare: allergic reactions — seek medical help if symptoms worsen

Precautions

• Not recommended during pregnancy or breastfeeding unless specifically advised by a physician.
• Inform your prescriber about liver disease, neurological conditions or concurrent medicines.

Storage

Store in a cool, dry place below 25°C. Keep out of reach of children.

Manufacturer

Globalstar International

Tirzepatide Injection is a once-weekly dual GIP/GLP-1 receptor agonist indicated for the treatment of type 2 diabetes in adults and may support clinically meaningful weight loss when used alongside diet and exercise. It combines actions on both GIP and GLP-1 pathways to improve glycaemic control and reduce appetite.

Key Benefits

• Improves blood glucose control by enhancing insulin secretion and lowering glucagon.
• Supports weight reduction through reduced appetite and delayed gastric emptying.
• Convenient once-weekly dosing in a prefilled pen for accurate administration.

Composition

Each pen delivers: Tirzepatide (strength as labelled: 2.5 mg / 5 mg / 7.5 mg / 10 mg / 12.5 mg / 15 mg).

How It Works

Tirzepatide acts on both GIP and GLP-1 receptors, improving insulin sensitivity, reducing post-prandial and fasting glucose levels, and decreasing appetite.

Usage Directions

• Administer subcutaneously once weekly as prescribed by a healthcare professional.
• Rotate injection sites; follow the prescribed titration schedule if applicable.
• Pens are for single-patient use only — do not share pens between patients.

Possible Side Effects

• Nausea, vomiting, diarrhea, constipation
• Decreased appetite
• Injection site reactions
• Rarely pancreatitis or gallbladder disorders

Precautions

• Not indicated for type 1 diabetes or treatment of diabetic ketoacidosis.
• Inform your prescriber if you have a history of pancreatitis, medullary thyroid carcinoma, or MEN2 (multiple endocrine neoplasia type 2).
• Use under medical supervision; monitor blood glucose closely when combined with insulin or sulfonylureas.

Storage Instructions

• Store refrigerated at 2°C–8°C prior to first use; follow manufacturer instructions for storage after first use.
• Do not freeze; protect from excessive heat and light.

Manufacturer

Globalstar International

Semaglutide Injection is a once-weekly GLP-1 receptor agonist used to improve glycaemic control in adults with type 2 diabetes and to support weight management when indicated. It works by enhancing insulin release, reducing glucagon secretion, and slowing gastric emptying.

Key Benefits

• Improves blood glucose control in type 2 diabetes
• Supports clinically meaningful weight reduction when combined with diet and exercise
• Convenient once-weekly dosing via a prefilled pen

Composition

Active ingredient: Semaglutide.

How It Works

Acts as a GLP-1 receptor agonist to increase insulin secretion in a glucose-dependent manner, decrease glucagon, and slow gastric emptying, thereby reducing appetite.

Usage Directions

• Inject subcutaneously once weekly as prescribed by a healthcare professional.
• Rotate injection sites and follow the prescribing information for dose titration.

Possible Side Effects

• Nausea, vomiting, diarrhea
• Decreased appetite
• Occasional dizziness

Precautions

• Not indicated for type 1 diabetes or diabetic ketoacidosis.
• Use under medical supervision; monitor for gastrointestinal effects and kidney function in susceptible patients.

Storage Instructions

• Store refrigerated at 2°C–8°C until first use; after first use follow pen storage instructions.
• Do not freeze; protect from direct heat and sunlight.

Manufacturer

Novo Nordisk